Last reviewed · How we verify
NCT04275882
Demographical and Clinical Profile of Patients With Left Ventricular Hypertrophy
trial testing Electrocardiogram in Left Ventricular Hypertrophy in 886 participants. Completed in 1 December 2021.
1 September 2021
Quick facts
| Lead sponsor | Cardiovascular Academy Society, Turkey |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 886 |
| Start date | 14 February 2020 |
| Primary completion | 1 September 2021 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Electrocardiogram
Conditions studied
- Left Ventricular Hypertrophy — all drugs for Left Ventricular Hypertrophy →
Sponsor
Cardiovascular Academy Society, Turkey
Who can join
Adults 18 to 90, any sex, with Left Ventricular Hypertrophy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Left ventricular hypertrophy (LVH) is the most common result of the heart trying to pump blood against the high afterload, as in hypertension and aortic stenosis.Although hypertension is the most common cause of LVH, LVH can also be found in athletes and cardiomyopathies or in storage disorders such as amyloidosis. In addition, genetic diseases also play an important role in the pathogenesis of LVH. Fabry disease is another disease that should be considered in patients with left ventricular hypertrophy.Left ventricular hypertrophy is a common and potentially modifiable cardiovascular risk factor that is frequently overlooked in clinical practice.The benefit of combining ECG and echocardiography in the diagnosis of LVH has been demonstrated.Early diagnosis and treatment-related regression of LVH, reduces adverse cardiovascular events and improves survival.Therefore, the investigators planned to perform a retrospective, observational LVH-TR study in order to determine the etiologic causes of LVH, the symptoms presented by the patients, and the effects of patients' demographic characteristics on LVH.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04275882
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Electrocardiogram
Trials testing the same drug.
- NCT07456852 — Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Ca · Phase 1, PHASE2 · not yet recruiting
- NCT07058064 — WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring) · NA · recruiting
- NCT06418633 — Variations in the Hemostatic System Induced by a Standardized Walking Test · NA · recruiting
- NCT06386185 — Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography · recruiting
- NCT05761171 — A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia · Phase 2 · active not recruiting
Other recruiting trials for Left Ventricular Hypertrophy
Currently open trials in the same condition.
- NCT07263204 — AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy · recruiting
- NCT05593055 — Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension · Phase 4 · recruiting
- NCT05388032 — Sodium Lowering Vascular Effects Trial · NA · recruiting
- NCT05942729 — Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data. · recruiting
- NCT03549559 — Imaging Histone Deacetylase in the Heart · NA · recruiting
Other Cardiovascular Academy Society, Turkey trials
Trials by the same sponsor.
- NCT03727984 — Re-hospitalized Patients With Acute Coronary Syndrome · completed
- NCT03364387 — Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish Population · completed
- NCT03601013 — Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Tur · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04275882 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardiovascular Academy Society, Turkey
- Last refreshed: 8 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04275882.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing